Warfarin Dosing Issues Emerge In Early Results From Medco/Mayo Research

Nearly three-fourths of early patient participants in a warfarin research project appear to need non-standard dosing of the drug based on genetic screening, Medco reported during its analyst day presentation Nov. 16